FDA-AstraZeneca Hearing
In essence FDA proposals merely change the seating arrangement on the deck of the sinking Titanic. Eli Lilly announced that it intends to seek FDA approval for a long-lasting injectable form of Zyprexa (taken once a month).
SSRI’s found to adversely affect newborns during first days of life Sat, 26 Jul 2003 Doctors prescribing antidepressant drugs (SSRIs) to pregnant women may be faced with liability claims, as these drugs are shown to adversely affect unborn and newborn babies’ central nervous system A new report in the Archives…
Bloomberg News reports (below) that Senator Charles Grassley has asked the Inspector General to investigate collusion between FDA officials and Merck. Citing handwritten notes prepared by a Merck executive document a meeting with FDA division director, Brian Harvey, suggesting a joint effort "to get the message out" to discredit Dr….
The New York Times reports that former FDA Commissioner, Dr. Lester Crawford "is under criminalo investigation by a federal grand jury over accusations of financial improprieties and false statements to Congress."
Incentives to Pharma Companies but Health Care Leaders Voice Doubts on Smallpox Inoculations Thu, 30 Jan 2003 The New York Times reports (below) that serious doubts about the president’s smallpox vaccination plan emerged at a Senate hearing Wednesday. The Washington Post reports (below) that "The hearing illustrated the growing tensions…
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.